| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Accurate detection of intracranial extension of jugulotympanic paraganglioma by [18F]FDOPA-PET/CT comparing to MRI
|
Araghi, Zahra Jamshidi
|
|
|
49 |
1 |
p. 412-414
|
article
|
| 2 |
Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker
|
De Picker, Livia J.
|
|
|
49 |
1 |
p. 164-173
|
article
|
| 3 |
Can the BMI-based dose regimen be used to reduce injection activity and to obtain a constant image quality in oncological patients by 18F-FDG total-body PET/CT imaging?
|
Xiao, Jie
|
|
|
49 |
1 |
p. 269-278
|
article
|
| 4 |
Cellular sources of TSPO expression in healthy and diseased brain
|
Nutma, Erik
|
|
|
49 |
1 |
p. 146-163
|
article
|
| 5 |
Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders
|
Leroy, Claire
|
|
|
49 |
1 |
p. 186-200
|
article
|
| 6 |
Correction to: Global experience with PSMA‑based alpha therapy in prostate cancer
|
Sathekge, Mike M.
|
|
|
49 |
1 |
p. 73
|
article
|
| 7 |
Current status and quality of radiomic studies for predicting immunotherapy response and outcome in patients with non-small cell lung cancer: a systematic review and meta-analysis
|
Chen, Qiuying
|
|
|
49 |
1 |
p. 345-360
|
article
|
| 8 |
Cyclotron production of 225Ac from an electroplated 226Ra target
|
Nagatsu, Kotaro
|
|
|
49 |
1 |
p. 279-289
|
article
|
| 9 |
Dosing 225Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity
|
Kratochwil, Clemens
|
|
|
49 |
1 |
p. 54-63
|
article
|
| 10 |
FDG-PET/CT in colorectal cancer: potential for vascular-metabolic imaging to provide markers of prognosis
|
Chen, Shih-hsin
|
|
|
49 |
1 |
p. 371-384
|
article
|
| 11 |
[18F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort
|
Lovinfosse, P.
|
|
|
49 |
1 |
p. 331-335
|
article
|
| 12 |
[18F]-Fluciclovine PET/CT for preoperative nodal staging in high-risk primary prostate cancer: final results of a prospective trial
|
Zanoni, Lucia
|
|
|
49 |
1 |
p. 390-409
|
article
|
| 13 |
From radiotracer to radiopharmaceutical: a philosophical approach
|
Boschi, Stefano
|
|
|
49 |
1 |
p. 3-6
|
article
|
| 14 |
68Ga-FAPI-04 vs. 18F-FDG in a longitudinal preclinical PET imaging of metastatic breast cancer
|
Ding, Fan
|
|
|
49 |
1 |
p. 290-300
|
article
|
| 15 |
Global experience with PSMA-based alpha therapy in prostate cancer
|
Sathekge, Mike M.
|
|
|
49 |
1 |
p. 30-46
|
article
|
| 16 |
Harmonisation of PET imaging features with different amyloid ligands using machine learning-based classifier
|
Kang, Sung Hoon
|
|
|
49 |
1 |
p. 321-330
|
article
|
| 17 |
Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies
|
Chauveau, Fabien
|
|
|
49 |
1 |
p. 201-220
|
article
|
| 18 |
High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics
|
Kesch, Claudia
|
|
|
49 |
1 |
p. 385-389
|
article
|
| 19 |
Imaging and dosimetry for alpha-particle emitter radiopharmaceutical therapy: improving radiopharmaceutical therapy by looking into the black box
|
Sgouros, George
|
|
|
49 |
1 |
p. 18-29
|
article
|
| 20 |
Imaging dysregulated calcium homeostasis in acute myocardial infarction with [68 Ga]Ga-NODAGAZOL
|
Ndlovu, Honest
|
|
|
49 |
1 |
p. 417-418
|
article
|
| 21 |
Imaging of the glioma microenvironment by TSPO PET
|
Zinnhardt, Bastian
|
|
|
49 |
1 |
p. 174-185
|
article
|
| 22 |
Imaging translocator protein expression with positron emission tomography
|
Wimberley, Catriona
|
|
|
49 |
1 |
p. 74-76
|
article
|
| 23 |
Increased [68 Ga]Ga-FAPI uptake in focal nodular hyperplasia in a patient with sigmoid colon cancer
|
Shang, Qihang
|
|
|
49 |
1 |
p. 415-416
|
article
|
| 24 |
Intra-articular use of radium dichloride ([223Ra] RaCl2) showed relevant anti-inflammatory response on experimental arthritis model
|
Corrêa, Luana Barbosa
|
|
|
49 |
1 |
p. 336-344
|
article
|
| 25 |
Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain
|
Wimberley, Catriona
|
|
|
49 |
1 |
p. 246-256
|
article
|
| 26 |
Modelling [18F]LW223 PET data using simplified imaging protocols for quantification of TSPO expression in the rat heart and brain
|
MacAskill, Mark G.
|
|
|
49 |
1 |
p. 137-145
|
article
|
| 27 |
National Cancer Institute support for targeted alpha-emitter therapy
|
Hong, Julie A.
|
|
|
49 |
1 |
p. 64-72
|
article
|
| 28 |
Novel CYP11B-ligand [123/131I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience
|
Heinze, Britta
|
|
|
49 |
1 |
p. 301-310
|
article
|
| 29 |
Positive [18F]fluoroethyltyrosine PET/MRI in suspected recurrence of growth hormone–producing pituitary adenoma in a paediatric patient
|
Veldhuijzen van Zanten, Sophie E. M.
|
|
|
49 |
1 |
p. 410-411
|
article
|
| 30 |
Preclinical evaluation of (S)-[18F]GE387, a novel 18-kDa translocator protein (TSPO) PET radioligand with low binding sensitivity to human polymorphism rs6971
|
Ramakrishnan, Nisha K.
|
|
|
49 |
1 |
p. 125-136
|
article
|
| 31 |
Prognostic value of regional myocardial flow reserve derived from 13N-ammonia positron emission tomography in patients with suspected coronary artery disease
|
von Felten, Elia
|
|
|
49 |
1 |
p. 311-320
|
article
|
| 32 |
Radiosynthesis and characterization of [18F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism
|
Lee, Sang Hee
|
|
|
49 |
1 |
p. 110-124
|
article
|
| 33 |
Reduced microglia activity in patients with long-term immunosuppressive therapy after liver transplantation
|
Dirks, Meike
|
|
|
49 |
1 |
p. 234-245
|
article
|
| 34 |
Role of a portable gamma-camera with optical view for margins assessment of pulmonary nodules resected by radioguided surgery
|
Vollmer, Ivan
|
|
|
49 |
1 |
p. 361-370
|
article
|
| 35 |
Supervised clustering for TSPO PET imaging
|
Schubert, Julia
|
|
|
49 |
1 |
p. 257-268
|
article
|
| 36 |
Targeted α-therapy in non-prostate malignancies
|
Jadvar, Hossein
|
|
|
49 |
1 |
p. 47-53
|
article
|
| 37 |
The false myth of “iodine allergy” also in nuclear medicine
|
Gómez-Perales, Jesús Luis
|
|
|
49 |
1 |
p. 1-2
|
article
|
| 38 |
TSPO imaging in animal models of brain diseases
|
Van Camp, Nadja
|
|
|
49 |
1 |
p. 77-109
|
article
|
| 39 |
What value can TSPO PET bring for epilepsy treatment?
|
Bouilleret, Viviane
|
|
|
49 |
1 |
p. 221-233
|
article
|
| 40 |
Why bother with alpha particles?
|
King, A. Paden
|
|
|
49 |
1 |
p. 7-17
|
article
|
Journal description